Cargando…

Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer

We previously reported a phase I clinical trial of a peptide vaccine ring finger protein 43 (RNF43) and 34‐kDa translocase of the outer mitochondrial membrane (TOMM34) combined with uracil‐tegafur (UFT)/LV for patients with metastatic colorectal cancer (CRC), and demonstrated the safety and immunolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamura, Junichiro, Sugiura, Fumiaki, Sukegawa, Yasushi, Yoshioka, Yasumasa, Hida, Jin‐ichi, Hazama, Shoichi, Okuno, Kiyotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980387/ https://www.ncbi.nlm.nih.gov/pubmed/29473265 http://dx.doi.org/10.1111/cas.13547

Ejemplares similares

Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
por: Kawamura, Junichiro, et al.
Publicado: (2018)

Visualization of lymphatic flow in laparoscopic colon cancer surgery using indocyanine green fluorescence imaging
por: Ushijima, Hokuto, et al.
Publicado: (2020)

Analysis of the clinical factors associated with anal function after intersphincteric resection for very low rectal cancer
por: Tokoro, Tadao, et al.
Publicado: (2013)

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients
por: Sato, Y, et al.
Publicado: (2004)

The technique for less infectious and earlier healing of stoma closure wound: negative pressure wound therapy with instillation and dwelling followed by primary closure
por: Yane, Yoshinori, et al.
Publicado: (2021)

A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)
por: Hazama, Shoichi, et al.
Publicado: (2014)

Effectiveness of negative pressure wound therapy with instillation and dwelling after stoma closure: a retrospective and propensity score matching analysis
por: Yane, Yoshinori, et al.
Publicado: (2022)

Hybrid method using laparoscopy and Lichtenstein's technique for incarcerated inguinal hernia in a patient with liver cirrhosis and severe varicose veins: A case report
por: Yane, Yoshinori, et al.
Publicado: (2021)

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides
Publicado: (1988)

Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL)
por: Smith, Pamela A., et al.
Publicado: (1997)

Proposal of a modified subclassification system for stage III colorectal cancer: A multi‐institutional retrospective analysis
por: Shinto, Eiji, et al.
Publicado: (2020)

Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2014)

MicroRNA-6826 and −6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer
por: Kijima, Taiki, et al.
Publicado: (2017)

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2022)

Laparoscopic repair of diaphragmatic hernia after radiofrequency ablation for hepatocellular carcinoma: Case report
por: Ushijima, Hokuto, et al.
Publicado: (2021)

Successful treatment of intractable chylous ascites after laparoscopic low anterior resection using lymphangiography and embolization with lipiodol: A case report
por: Ushijima, Hokuto, et al.
Publicado: (2021)

Quantitative studies on the precursors of cytotoxic lymphocytes. III. The lineage of memory cells
Publicado: (1977)

Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes
por: Akazawa, Yu, et al.
Publicado: (2019)

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C(3)) study
por: Nagasaka, Takeshi, et al.
Publicado: (2016)

Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III
por: Marggraf, Mariana B., et al.
Publicado: (2018)

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer
por: Kim, Jae Hyun, et al.
Publicado: (2017)

miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2017)

Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
por: Zhu, Yankun, et al.
Publicado: (2023)

Correction: Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2023)

CYTOTOXICITY MEDIATED BY SOLUBLE ANTIGEN AND LYMPHOCYTES IN DELAYED HYPERSENSITIVITY : III. ANALYSIS OF MECHANISM
por: Ruddle, Nancy H., et al.
Publicado: (1968)

Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes
Publicado: (1992)

Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes
Publicado: (1989)

Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer
por: Shen, Yuanyuan, et al.
Publicado: (2020)

Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte‐specific protein tyrosine kinase
por: Matsueda, Satoko, et al.
Publicado: (2018)

Role of cytotoxic T lymphocytes and interferon-γ in coronavirus infection: Lessons from murine coronavirus infections in mice
por: KYUWA, Shigeru, et al.
Publicado: (2020)

Novel Survivin Peptides Screened With Computer Algorithm Induce Cytotoxic T Lymphocytes With Higher Cytotoxic Efficiency to Cancer Cells
por: Chen, Qiuqiang, et al.
Publicado: (2020)

Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells
por: Hoff, Antje, et al.
Publicado: (2010)

Generation of molecular-targeting helix-loop-helix peptides for inhibition of the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the dog
por: RAMANAYAKE MUDIYANSELAGE, Tharanga MR, et al.
Publicado: (2022)

Prognostic significance of CD8(+) tumor-infiltrating lymphocytes and CD66b(+) tumor-associated neutrophils in the invasive margins of stages I–III colorectal cancer
por: Yin, Chengzeng, et al.
Publicado: (2022)

Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
por: Cho, Yerim, et al.
Publicado: (2023)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
por: Derakhshani, Afshin, et al.
Publicado: (2021)

NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis
por: Fionda, Cinzia, et al.
Publicado: (2022)

Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa
por: Bowen, Charles M., et al.
Publicado: (2023)

Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
por: Tanaka, Koji, et al.
Publicado: (2002)

Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
por: SAWADA, YU, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5ub8hp96kn86l20tvhd9f6juum